Vidya

[Vidya @VRejeki28]

Breakfast Cath Menu for today
XTa - Gaia Next2 successfully penetrated the cap and Pilot 150 finally crossed to distal 😍

#CTO

[Tsutomu Fujita MD @Laserrman]

https://t.co/GpOMvCTitI

#TDADR #BASE #CT0 Congrats @VRejeki28

[Vidya @VRejeki28]

@SKuramitsu0511 @Laserrman @SCVC2023 Thank you for the opportunity Sensei 🙇‍♀️🙇‍♀️🙇‍♀️

[Shoichi Kuramitsu, MD, PhD, FACC, FJCS, FSCAI @SKuramitsu0511]

Our new case report has been published online at CCI. This case indicates that the BASE-facilitated TD-ADR is a good antegrade approach for CTO lesions with ambiguous proximal cap. Congrats, Vidya!

https://t.co/5cvJvu8eGg

@Laserrman @VRejeki28 @SCVC2023

[Vidya @VRejeki28]

Recent Inferior MI with very well organized thrombus

[Vidya @VRejeki28]

Thank you Sensei, it was teamwork 🙇‍♀️

[Vidya @VRejeki28]

Poor GC selection not enough backup to reach the destination… successfully penetrated the distal after better backup. Yet it was not true cto… mostly organized thrombus from mid RCA in recent STEMI without previous revacularization.

[Vidya @VRejeki28]

@Laserrman @sapporohunt Thank you so much for the warm welcome and the opportunities throughout our training Sensei 🤗🤗🤗

[Tsutomu Fujita MD @Laserrman]

My dose was at 1.7 microsievert (uSv) - it equates to eating 6 Brazil nuts. At this average and if I do 1000 cases per year (lead free), I am only on 9% on my allowable 20 millisievert (mSv) limit . Yearly background radiation received by a person just living on the planet, is 2.4mSv (this radiation comes from the sun, soil, etc.) @RAMPARTic
@VRejeki28 @calcbreaker

[Tsutomu Fujita MD @Laserrman]

@RAMPARTic
Our 1st case. Good protection for radiation.